Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Lowin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Medical Economics|January 18, 2011
The economic burden of advanced Parkinson’s disease: an analysis of a UK patient datasetLeslie J Findley, Eifiona Wood, Julia Lowin, et al.
The Journal of Family Planning and Reproductive Health Care|December 25, 2014
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraceptionNathaniel Henry, Max Schlueter, Julia Lowin, et al.
Journal of Medical Economics|October 8, 2016
The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care settingRadek Wojcik, Julia Lowin, David Vilardell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2017
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in FranceMickael Basson, Dionysios Ntais, Ruba Ayyub, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 5, 2015
The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible ContraceptivesAmanda Y Black, Edith Guilbert, Fareen Hassan, et al.
Journal of Medical Economics|September 13, 2017
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's diseaseJulia Lowin, Kavita Sail, Rakhi Baj, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2023
The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non-Small Cell Lung CancerMari Jones, Julia Lowin, Bernadette Sewell, et al.
Journal of Medical Economics|July 7, 2011
A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UKJulia Lowin, Annika Bergman, K Ray Chaudhuri, et al.
Journal of Medical Economics|April 6, 2013
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in SwedenSten Fredrikson, Euan McLeod, Nathaniel Henry, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Medical Economics|January 18, 2011
The economic burden of advanced Parkinson’s disease: an analysis of a UK patient datasetLeslie J Findley, Eifiona Wood, Julia Lowin, et al.
The Journal of Family Planning and Reproductive Health Care|December 25, 2014
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraceptionNathaniel Henry, Max Schlueter, Julia Lowin, et al.
Journal of Medical Economics|October 8, 2016
The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care settingRadek Wojcik, Julia Lowin, David Vilardell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2017
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in FranceMickael Basson, Dionysios Ntais, Ruba Ayyub, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 5, 2015
The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible ContraceptivesAmanda Y Black, Edith Guilbert, Fareen Hassan, et al.
Journal of Medical Economics|September 13, 2017
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's diseaseJulia Lowin, Kavita Sail, Rakhi Baj, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2023
The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non-Small Cell Lung CancerMari Jones, Julia Lowin, Bernadette Sewell, et al.
Journal of Medical Economics|July 7, 2011
A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UKJulia Lowin, Annika Bergman, K Ray Chaudhuri, et al.
Journal of Medical Economics|April 6, 2013
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in SwedenSten Fredrikson, Euan McLeod, Nathaniel Henry, et al.
Pageof 2